Search the web
Welcome, Guest
[Sign Out, My Account]
Hoovers

Wednesday, June 19 2013 3:48pm ET - U.S. Markets close in 12 minutes.
Industry Center
Industry Center > > Ranbaxy Laboratories Limited Company Profile
More On This Industry
· Summary
· News
· Leaders & Laggards
· Company Index
·Industry Browser
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Need more? Get unbiased, in-depth information on public and private companies worldwide.
  
Ranbaxy Laboratories Limited Company Profile
Ranbaxy Laboratories is quite the rainmaker in India's pharmaceutical business. The company is one of India's largest drug manufacturers and a top global generics producer. Anti-infectives amoxycillin (not to be confused with the common antibiotic, amoxicillin) and ciprofloxacin, and cardio drug simvastatin are among Ranbaxy's top sellers; all come in several administration forms. The company also makes treatments for gastrointestinal, musculoskeletal, and central nervous system disorders, as well as diabetes, pain, allergies, and HIV/AIDS. Its R&D focus includes new forms of existing drugs and metabolic disease treatments. Japanese drugmaker Daiichi Sankyo owns a controlling stake in Ranbaxy.
Headlines for Ranbaxy Laboratories Limited
Ranbaxy Announces Improved Business Standards and Quality Assurance Initiatives
- Wed May 22
Ranbaxy drops 4% to record 4 year low
- Tue 3:03 am ET
Japan's Daiichi says key details 'concealed' in Ranbaxy sale
- Wed May 22
Ranbaxy to appeal against EU fine
- Wed 11:08 am ET
EU regulator fines Ranbaxy, 8 others over Citalopram generic delay
- Wed 6:55 am ET
Ranbaxy US facility held for violations in 2009
- Tue May 28
Ranbaxy Highlights Improved Business and Quality Assurance Standards
- Wed May 22
Top corporate news of the day
- Thu Jun 6
Adulterated drugs: Mumbai hospital stops Ranbaxy products
- Wed Jun 5
Ranbaxy got FDA raps on US facilities under Daiichi, too
- Tue May 28
Contact Information
Address: Plot 90, Sector 32
Gurgaon, Haryana 122001, India
Phone:+91-124-413-5000
Fax:+91-124-413-5001
Financial Highlights
Fiscal Year End:December
Revenue (2011):1863.60 M
Revenue Growth (1 yr):(-5.30%)
Employees (2011):14,042
Employee Growth (1 yr):4.60%
Key People
Chairman: Tsutomu Une
Managing Director: Arun Sawhney
General Manager Corporate Communications: Krishnan Ramalingam
Industry Information
Sector:
Industry:
Top Competitors
Sandoz International GmbH
Sun Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited (teva)
 


Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2013 Morningstar, Inc. All Rights Reserved. Company information © 2013 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2013, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo! nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo! site, a user agrees not to redistribute the information found therein.

Questions or Comments?